Our team comprises of accomplished scientist-entrepreneurs with novel foresight to imagine innovative solutions and products.
Dr. Ronald Hoffman, MD, is a leader in stem cell research. His studies of human hematopoietic stem cells and progenitor cells in hematological neoplasms have led to many therapeutic advances. He has pioneered a unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders.
Dr
Dr. Ronald Hoffman, MD, is a leader in stem cell research. His studies of human hematopoietic stem cells and progenitor cells in hematological neoplasms have led to many therapeutic advances. He has pioneered a unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders.
Dr. Hoffman has served as president of the American Society of Hematology and the International Society for Experimental Hematology. He is the editor of Hematology: Basic Principles and Practice. He conceptualized and organized this leading textbook of hematology, which is currently entering its eighth edition. He is an author on almost 500 peer-reviewed publications and 130 books/book chapters/reviews. He has also served as the editor of the journal Experimental Hematology.
Dr. Hoffman is the Albert A. and Vera G. List Professor of Medicine, Professor of Medicine (Hematology and Medical Oncology), and Director of the Myeloproliferative Disorders Research Program. In 2017 Dr. Hoffman received the prestigious Mentor Award from American Society of Hematology in recognition of his outstanding commitment to the training and career development of early-career hematologists and advancing research and patient care in hematology.